Ly-34: a new mouse lymphocyte alloantigen

1987 ◽  
Vol 26 (6) ◽  
pp. 381-382 ◽  
Author(s):  
Shoji Kimura ◽  
Jill Furze ◽  
Hilliard Festenstein
Keyword(s):  
Mouse Lymphocyte ◽  
Lymphocyte Alloantigen

A new mouse lymphocyte alloantigen (Ly-28) defined by monoclonal antibodies

1986 ◽  
Vol 24 (4) ◽  
pp. 275-277 ◽  
Author(s):  
Nobuhiko Tada ◽  
Norikazu Tamaoki ◽  
Shuji Ikegami ◽  
Shuji Nakamura ◽  
Kazuo Dairiki ◽  
...  
Keyword(s):  
Monoclonal Antibodies ◽  
Mouse Lymphocyte ◽  
Lymphocyte Alloantigen

A new mouse lymphocyte alloantigen (Ly-35) controlled by the Ly-2/3 region on chromosome 6

1988 ◽  
Vol 27 (4) ◽  
pp. 293-294 ◽  
Author(s):  
Shuji Ikegamil ◽  
Shuji Nakamura ◽  
Kazuo Dairiki ◽  
Yuki Watanabe ◽  
Takao Fujimori ◽  
...  
Keyword(s):  
Chromosome 6 ◽  
Mouse Lymphocyte ◽  
Lymphocyte Alloantigen

The effect of dental alloys on mouse lymphocyte subpopulations

1998 ◽  
Vol 25 (2) ◽  
pp. 106-109 ◽  
Author(s):  
Zalkind ◽  
Calderon ◽  
Rabinowitz ◽  
Hadar ◽  
Schlesinger
Keyword(s):  
Lymphocyte Subpopulations ◽  
Dental Alloys ◽  
Mouse Lymphocyte

Effects of a Single Dose of Rabbit Anti-mouse Lymphocyte Serum on Tumors Induced in Mice by 7,12-Dimethylbenz (a) anthracene Given at Birth

1972 ◽  
Vol 58 (6) ◽  
pp. 397-408 ◽  
Author(s):  
Carlo D. Baroni ◽  
Pietro Mingazzini ◽  
Paolo Pesando ◽  
Anna Cavallero ◽  
Stefania Uccini ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Single Dose ◽  
Malignant Lymphoma ◽  
Single Injection ◽  
Latency Period ◽  
Skin Tumors ◽  
Rabbit Serum ◽  
Normal Rabbit Serum ◽  
Malignant Lymphomas ◽  
Mouse Lymphocyte

The effects of ALS (anti-lymphocyte serum) and NRS (normal rabbit serum) treatments on the development of malignant lymphoma, lung, subcutaneous and skin tumors induced in mice by 7,12-dimethylbenz (a) anthracene (DMBA) are described. Groups of Charles-River mice, injected at birth with a dose of 100 μg of DMBA, received a single injection of ALS or NRS at the same time as DMBA administration or 10, 20, 30, 40 and 50 days after birth. Incidence, latency, histology and spread of the tumors were studied in all groups. It was found that both ALS and NRS increased tumor incidence and shortened their latency period. Malignant lymphomas were the main tumors whose latency was shortened either by ALS or NRS treatment. In addition ALS treatment apparently increased dissemination of DMBA induced lymphoma in bone marrow.

A comparison of the in vitro and in vivo activities of conjugates of anti-mouse lymphocyte globulin and abrin

1982 ◽  
Vol 717 (2) ◽  
pp. 272-277 ◽  
Author(s):  
D.C. Edwards ◽  
W.C.J. Ross ◽  
A.J. Cumber ◽  
D. McIntosh ◽  
A. Smith ◽  
...  
Keyword(s):  
Mouse Lymphocyte
Sign in / Sign up

Export Citation Format

Share Document